Our Nigeria office opened in Abuja in 2012 and has been working to help the country and its partners address an array of major health and development challenges. Our investments include support for ...

to demonstrate a rapid, low-cost, point-of-care test capable of accurately detecting active schistosomiasis and soil-transmitted helminth infections in low and middle income countries, where access to ...

To develop improved delayed‑release vaccine delivery approaches that simplify immunization and support broader access to effective vaccines for people in low‑income communities.

To leverage genetic surveillance to accelerate malaria elimination in the Greater Mekong Subregion ...